Tandem Source

Tandem Source is a platform for healthcare providers to see important diabetes therapy data, access patient reports, and find the tools to help patients manage their diabetes.

Three Easy Reports

Having easy access to your patient's therapy data in one convenient platform is critical to help them — and you — successfully manage their diabetes. No more switching between dashboards and websites.

Overview

Provides an overview of the patient’s therapy data from their insulin pump.

Daily Timeline

Shows glucose readings, basal insulin delivery, and boluses over time.

Pump Settings

Displays the pump settings, including Personal Profiles and predictive technology.

Streamline Office Visits

t:connect mobile app

When your patients use the t:connect mobile app, their t:slim X2 insulin pump and therapy data are uploaded to Tandem Source every hour,* eliminating the need to plug in their pumps and upload during an office visit.

Web-Based UploaderIf you need to directly upload a patient’s pump data, you do not need to install the uploader on your clinic computer.

Make Impactful Adjustments

With Control-IQ Technology

Control-IQ technology is an automated insulin delivery system that decreases or stops basal insulin if readings from compatible continuous glucose monitoring (CGM)^† are predicted to be low. It also increases basal insulin if sensor readings are predicted to be high.

Get step-by-step guidance on clinical assessment and how to make insulin dose adjustments using the Tandem Source platform.

Download Now

Get Started

View reports, make adjustments, or upload pump data.

(Current t:connect HCP users can log in with the same credentials)

Go to Tandem Source

Support Resources

Tandem Source User Guide

Tandem Source System Requirements

* The information on the t:connect mobile app display may not be identical to the current status of the user’s pump. Wireless uploads from the t:connect mobile app to the cloud-based t:connect web application require a compatible phone and an internet or wireless data connection. Uploads to the t:connect web application do not take place in real time and should not be relied upon by healthcare providers or caregivers for remote patient monitoring. Standard carrier data rates may apply.

† CGM sold separately.

Important Safety Information

RX ONLY. The t:slim X2 pump and Control-IQ technology are intended for single patient use. The t:slim X2 pump and Control-IQ technology are indicated for use with NovoLog or Humalog U-100 insulin.

t:slim X2 insulin pump: The t:slim X2 insulin pump with interoperable technology is an alternate controller enabled (ACE) pump that is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The t:slim X2 pump is indicated for use in individuals six years of age and greater. Control-IQ technology: Control-IQ technology is intended for use with a compatible integrated continuous glucose monitor (iCGM, sold separately) and ACE pump to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ technology is intended for the management of Type 1 diabetes mellitus in persons six years of age and greater.

WARNING: Control-IQ technology should not be used by anyone under the age of six years old. It should also not be used in patients who require less than 10 units of insulin per day or who weigh less than 55 pounds.

Control-IQ technology is not indicated for use in pregnant women, people on dialysis, or critically ill patients. Do not use Control-IQ technology if using hydroxyurea. Users of the t:slim X2 pump and Control-IQ technology must: use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders. The t:slim X2 pump and the CGM transmitter and sensor must be removed before MRI, CT, or diathermy treatment. Visit www.tandemdiabetes.com/safetyinfo for additional important safety information.

t:connect mobile app: The t:connect mobile app is intended to be a secondary display for compatible Tandem Diabetes Care insulin pumps and is capable of wirelessly uploading pump data it receives into the t:connect web application. The t:connect mobile app is not intended to control an insulin pump and is not intended to be a replacement for the information displayed on your insulin pump. Dosing decisions should not be made based on the secondary display device. The user should follow instructions on the continuous glucose monitoring system and insulin pump.

The Tandem Source platform is intended for use by individuals with diabetes mellitus who use Tandem Diabetes Care insulin pumps, their caregivers, and their healthcare providers in home and clinical settings. The Tandem Source platform supports diabetes management through the display and analysis of information uploaded from Tandem insulin pumps.